Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Anavex Life Sciences Corp (AVXL)

187 + Investors. Track Smart Money conviction in AVXL. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +2
Streak
3Q ▲
Buyers last Q
58%

Smart Money Signals — AVXL

Based on 188 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added AVXL than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
188 hedge funds hold AVXL right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
〰️

Stable — ownership unchanged year-over-year

fund count last 6Q
The number of hedge funds holding AVXL is almost the same as a year ago (+5 funds, +3% change). No significant rush to buy or sell — institutional backing is holding steady.
🟡

Slight buying edge — 58% buying

113 buying83 selling
Last quarter: 113 funds bought or added vs 83 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~37 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 23 → 29 → 32 → 37. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

52% of holders stayed for 2+ years

■ 52% conviction (2yr+) ■ 28% medium ■ 20% new
97 out of 188 hedge funds have held AVXL for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +5%, value -37%

Value
-36%
Shares
+4%
Last quarter: funds added +5% more shares while total portfolio value only changed -37%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

38 → 23 → 29 → 32 → 37 new funds/Q
New funds entering each quarter: 23 → 29 → 32 → 37. A growing number of institutions are discovering AVXL each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Deep conviction — 59% of holders stayed 2+ years

■ 59% veterans ■ 15% 1-2yr ■ 26% new
Of 195 current holders: 115 (59%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
🏆

Elite ownership — 41% AUM from top-100 funds

41% from top-100 AUM funds
43 of 188 holders are among the 100 largest funds by AUM, controlling 41% of total institutional value in AVXL. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.6
out of 10
Low Exit Risk
Exit risk score 3.6/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — AVXL

In 2026 Q1, 113 hedge funds were net buyers of AVXL (37 opened a new position, 76 added to an existing one), while 83 reduced or exited (48 trimmed, 35 sold completely) — a 58% buyer ratio, indicating a slight buying edge. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. 41% of total institutional value in AVXL is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +2 funds (more new holders than closures). Total institutional holders: 188.

Hedge Fund Ownership: AVXL

How many hedge funds hold AVXL — quarterly history vs. share price
Quarterly hedge fund ownership of AVXL vs. share price

Market Analysis: AVXL

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: AVXL

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Anavex Life Sciences Corp (AVXL) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much AVXL has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 76d ago
AVXL
-18.6%
XLV
+4.5%

AVXL outperformed XLV by -23.1% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 31d ago
AVXL
-14.1%
XLV
+5.6%

Since the filing became public, AVXL outperformed XLV by -19.7% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

21 top-rated funds 0 high-conviction
Consensus
5.8
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: AVXL
187 + Investors

Track Smart Money conviction in AVXL. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 187 186 0.54%
13F Shares 43M 41M 4.56%
Total Value $132M $209M -36.74%
New Positions 36 32 +4
Increased Positions 74 66 +8
Closed Positions 35 30 +5
Reduced Positions 45 52 -7
Total Calls 8 10 -20.0%
Total Puts 3 7 -57.14%
PUT/CALL Ratio 0.38 0.7 Bullish

Statistics: AVXL

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

187 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in AVXL. Verified SEC 13F-HR filings.

QUARTER:
Top 25 AVXL holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Great Point Partners LLC 0.37% 521,300 $1.6M
2 Diadema Partners LP 0.25% 477,600 $1.5M
3 October Effect Ltd 0.05% 15,250 $47K
4 180 Wealth Advisors, LLC 0.04% 119,475 $367K
5 Sheets Smith Wealth Management 0.04% 117,805 $362K
6 Graetz Wealth LLC 0.04% 14,044 $43K
7 Innovative Asset Advisors Group, LLC 0.04% 21,100 $65K
8 Summit Financial, LLC 0.04% 940,455 $2.9M
9 LexAurum Advisors, LLC 0.03% 67,450 $207K
10 Yukon Wealth Management, Inc. 0.02% 12,045 $37K
11 XTX Topco Ltd 0.01% 258,071 $792K
12 Hamilton Point Investment Advisors, LLC 0.01% 20,300 $62K
13 Bnc Wealth Management, LLC 0.01% 11,250 $35K
14 Strategic Family Wealth Counselors, L.L.C. 0.01% 11,000 $34K
15 Two Sigma Securities, LLC 0.01% 24,201 $74K
16 Two Sigma Advisers, LP 0.01% 1,209,570 $4.3M
17 Apella Capital, LLC 0.01% 153,006 $557K
18 Gladstone Institutional Advisory LLC 0.01% 72,381 $222K
19 Two Sigma Investments, LP 0.01% 3,247,888 $10.0M
20 Profund Advisors LLC 0.01% 64,223 $197K
21 Private Advisor Group, LLC 0.01% 499,700 $1.5M
22 Foster Victor Wealth Advisors, LLC 0.01% 39,925 $125K
23 Strategic Family Wealth Counselors, L.L.C. 0.01% 8,045 $25K
24 Headlands Technologies LLC 0.01% 17,167 $53K
25 Millstone Evans Group, LLC 0.01% 3,000 $9K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Anavex Life Sciences Corp (AVXL)

What does the Smart Money Trend signal show for AVXL?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added AVXL than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for AVXL?

Slight buying edge — 58% buying: Last quarter: 113 funds bought or added vs 83 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for AVXL holders?

Elite ownership — 41% AUM from top-100 funds: 43 of 188 holders are among the 100 largest funds by AUM, controlling 41% of total institutional value in AVXL. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held AVXL?

52% of holders stayed for 2+ years: 97 out of 188 hedge funds have held AVXL for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Anavex Life Sciences Corp (AVXL) following the 2026 Q1 hedge fund 13F filings?

As of today, AVXL has moved -14.1% since the 2026 Q1 13F filing date (May 15, 2026), compared to +5.6% for the XLV sector ETF — an outperformance of -19.7%. Since the quarter end (March 31, 2026), AVXL has gained -18.6% vs +4.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →